Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

BRTX

BioRestorative Therapies (BRTX)

BioRestorative Therapies Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BRTX
DateTimeSourceHeadlineSymbolCompany
04/16/202410:25AMAllPennyStocks.comBiotech Catches Major Premarket Bid Following FDA ClearanceNASDAQ:BRTXBioRestorative Therapies Inc
04/16/20247:45AMGlobeNewswire Inc.BioRestorative Therapies Announces FDA Clearance of Phase 2 BRTX-100 Clinical Study Protocol AmendmentNASDAQ:BRTXBioRestorative Therapies Inc
04/08/20247:45AMGlobeNewswire Inc.BioRestorative Therapies Partners with Galen Patient Recruitment to Accelerate Completion of Enrollment in Phase 2 Trial of BRTX-100 in Chronic Lumbar Disc DiseaseNASDAQ:BRTXBioRestorative Therapies Inc
04/03/20244:38PMGlobeNewswire Inc.BioRestorative Therapies Announces Filing of Form S-1 Registration Statement to Register for Resale Common Stock Underlying Previously Issued WarrantsNASDAQ:BRTXBioRestorative Therapies Inc
04/01/20247:45AMGlobeNewswire Inc.BioRestorative Therapies Announces Filing of 2023 Annual Report on Form 10-KNASDAQ:BRTXBioRestorative Therapies Inc
03/11/20244:15PMGlobeNewswire Inc.BioRestorative Therapies to Participate in the 36th Annual ROTH ConferenceNASDAQ:BRTXBioRestorative Therapies Inc
03/06/20244:34PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:BRTXBioRestorative Therapies Inc
02/15/20244:43PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:BRTXBioRestorative Therapies Inc
02/15/20244:40PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:BRTXBioRestorative Therapies Inc
02/15/20244:27PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BRTXBioRestorative Therapies Inc
02/15/20244:25PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BRTXBioRestorative Therapies Inc
02/15/20244:23PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BRTXBioRestorative Therapies Inc
02/15/20244:19PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BRTXBioRestorative Therapies Inc
02/15/20244:17PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BRTXBioRestorative Therapies Inc
02/15/20244:13PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BRTXBioRestorative Therapies Inc
02/15/20244:11PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BRTXBioRestorative Therapies Inc
02/14/20241:44PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:BRTXBioRestorative Therapies Inc
02/12/20249:26AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BRTXBioRestorative Therapies Inc
02/09/20248:00AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BRTXBioRestorative Therapies Inc
02/08/20244:09PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BRTXBioRestorative Therapies Inc
02/06/20248:05AMGlobeNewswire Inc.BioRestorative Therapies Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $8.1 Million Gross Proceeds Priced At-the-MarketNASDAQ:BRTXBioRestorative Therapies Inc
02/05/20248:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BRTXBioRestorative Therapies Inc
02/05/20247:30AMGlobeNewswire Inc.BioRestorative Therapies Presents Preliminary Clinical Data from Phase 2 Study of BRTX-100 in Chronic Lumbar Disc DiseaseNASDAQ:BRTXBioRestorative Therapies Inc
02/01/20244:43PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BRTXBioRestorative Therapies Inc
02/01/20247:30AMGlobeNewswire Inc.BioRestorative Therapies to Present Preliminary BRTX-100 Clinical Data at the Orthopaedic Research Society (ORS) 2024 Annual MeetingNASDAQ:BRTXBioRestorative Therapies Inc
12/12/20239:15AMGlobeNewswire Inc.BioRestorative Therapies Receives a Notice of Allowance by the United States Patent and Trademark Office for a Patent Application Related to its Obesity ProgramNASDAQ:BRTXBioRestorative Therapies Inc
12/05/20234:32PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BRTXBioRestorative Therapies Inc
12/01/20235:04PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BRTXBioRestorative Therapies Inc
11/15/20234:14PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:BRTXBioRestorative Therapies Inc
10/09/202312:10PMGlobeNewswire Inc.BioRestorative Therapies, Inc. to Participate at the ROTH MKM Healthcare Opportunities Conference October 12, 2023 in New York CityNASDAQ:BRTXBioRestorative Therapies Inc
 Showing the most relevant articles for your search:NASDAQ:BRTX